[go: up one dir, main page]

Grunbaum et al., 2022 - Google Patents

Parathyroid hormone-related protein (PTHrP) and malignancy

Grunbaum et al., 2022

Document ID
12756015683356732707
Author
Grunbaum A
Kremer R
Publication year
Publication venue
Vitamins and Hormones

External Links

Snippet

PTHrP (parathyroid hormone related protein) is an important mediator of malignancy-related tumor progression and hypercalcemia that shares considerable homology and functionality with parathyroid hormone. In this chapter, we review what has been elucidated to date …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F9/00—Arrangements for programme control, e.g. control unit
    • G06F9/06—Arrangements for programme control, e.g. control unit using stored programme, i.e. using internal store of processing equipment to receive and retain programme
    • G06F9/30—Arrangements for executing machine-instructions, e.g. instruction decode
    • G06F9/30003—Arrangements for executing specific machine instructions
    • G06F9/30007—Arrangements for executing specific machine instructions to perform operations on data operands

Similar Documents

Publication Publication Date Title
Grunbaum et al. Parathyroid hormone-related protein (PTHrP) and malignancy
Vermeulen et al. Sex hormone concentrations in post-menopausal women.
Metzger et al. Relation between circulating levels of 25 (OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold
Heidari et al. Insulin resistance associated with differentiated thyroid carcinoma: penalized conditional logistic regression analysis of a matched case-control study data
OuYang et al. Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma
Zhang et al. Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia
Fangzheng et al. Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis
Farooki NCCN bone health task force: key recommendations
Wu et al. Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
Yang et al. Thyroid cancer benefits the prognosis of ovarian cancer: a SEER-based study
Malik et al. Immuno-histochemical analysis of estrogen receptors on the malignant gallbladder tissue.
Hugentobler et al. 18F-fluorocholine PET/CT of incidental male breast cancer
Lewin et al. Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma
Lu et al. Optimal duration of adjuvant bisphosphonate treatment for high‐risk early breast cancer: Results from a SUCCESS trial
Stojceva-Taneva et al. Hypercalcemia as a cause of kidney failure: case report
Flores-Rebollar et al. Effect of 1110 MBq radioiodine in reducing thyroid volume in multinodular goiter: a new protocol
Kumar et al. Bilateral gynecomastia: A rare presentation of thyrotoxicosis
Ragate et al. Idiopathic hypercalcemia in decompensated cirrhosis: reexploring an entity in oblivion
Cai et al. Hypercalcemia caused by concomitant Graves disease and primary hyperparathyroidism
Velikanova et al. The relationship between urine steroid metabolome and the course of adrenocortical cancer
Anderson et al. Predictors for survival after radium-223 treatment for castration-resistant metastatic prostate cancer
Rossato et al. Elevated plasma levels of the novel hormone INSL3 in a woman with metastatic ovarian cancer
Trimarchi et al. Thyroid and its Diseases in Breast Cancer
Tančić-Gajić et al. Complete androgen insensitivity syndrome
Victor et al. The role of 99mTc-sestamibi in amiodarone-induced thyrotoxicosis-Case report